Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
Status:
Completed
Trial end date:
2017-02-22
Target enrollment:
Participant gender:
Summary
A double-blind, phase 3 study to determine the efficacy of SPL7013 Gel when administered on
alternate days for 16 weeks, compared to placebo gel in preventing the recurrence of BV in
women with a history of recurrent BV.